VeriMom¿Es hexapeptide-45 seguro durante el embarazo?
No harmonised CLP reproductive classifications found (ECHA Annex VI) and no SCCS or CIR safety opinion specifically identifying reproductive hazards for hexapeptide-45. No peer‑reviewed reproductive or developmental toxicity studies located in PubMed for this ingredient; as a short peptide it is expected to have low dermal systemic absorption from cosmetic use (PubChem, CosIng). Based on these authoritative absences, default to no evidence of reproductive hazard. (Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, PubChem, CosIng.)
Related ingredients
Frequently asked questions
- ¿Es hexapeptide-45 seguro durante el embarazo?
- No harmonised CLP reproductive classifications found (ECHA Annex VI) and no SCCS or CIR safety opinion specifically identifying reproductive hazards for hexapeptide-45. No peer‑reviewed reproductive or developmental toxicity studies located in PubMed for this ingredient; as a short peptide it is expected to have low dermal systemic absorption from cosmetic use (PubChem, CosIng). Based on these authoritative absences, default to no evidence of reproductive hazard. (Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, PubChem, CosIng.)
- ¿Es hexapeptide-45 seguro durante la lactancia?
- No data or regulatory flags (ECHA Annex VI, SCCS, CIR) indicating hazards for lactation or transfer into breast milk. No studies found in PubMed showing placental or milk transfer for hexapeptide-45; peptides of this size applied topically are generally poorly absorbed systemically (PubChem, CosIng), so breastfeeding exposure is expected to be negligible under normal cosmetic use.
- ¿Es hexapeptide-45 seguro para la piel del bebé?
- No evidence of infant-specific developmental or dermal toxicity (no SCCS/CIR/toxicology studies located). Hexapeptides are relatively large and polar, so adult dermal absorption is expected to be negligible (adult e=0), but because infant skin has higher surface‑area-to‑weight and an immature barrier, increase exposure rating by one (e=1) to reflect low but potentially measurable absorption in 0–3 yr skin. No data indicate increased hazard (h=0) or a specific reproductive mechanism (m=0).
- ¿Cómo puntúa VeriMom a hexapeptide-45?
- VeriMom puntúa hexapeptide-45 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a hexapeptide-45 en el embarazo?
- Consulta nuestra lista de alternativas seguras a hexapeptide-45 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.